These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 16596620)
1. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Furtwaengler R; Reinhard H; Leuschner I; Schenk JP; Goebel U; Claviez A; Kulozik A; Zoubek A; von Schweinitz D; Graf N; Cancer; 2006 May; 106(10):2275-83. PubMed ID: 16596620 [TBL] [Abstract][Full Text] [Related]
2. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957 [TBL] [Abstract][Full Text] [Related]
3. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology. Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220 [TBL] [Abstract][Full Text] [Related]
13. Outcome of solid renal tumours in children at the University Hospital of the West Indies. Venugopal S; Shah DJ; Duncan ND; Carpenter R West Indian Med J; 1994 Dec; 43(4):134-7. PubMed ID: 7900377 [TBL] [Abstract][Full Text] [Related]
14. Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH. Haecker FM; von Schweinitz D; Harms D; Buerger D; Graf N J Urol; 2003 Sep; 170(3):939-42; discussion 943-4. PubMed ID: 12913746 [TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour. Taran K; Sitkiewicz A; Andrzejewska E; Kobos J Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463 [TBL] [Abstract][Full Text] [Related]
17. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
19. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. London WB; Castleberry RP; Matthay KK; Look AT; Seeger RC; Shimada H; Thorner P; Brodeur G; Maris JM; Reynolds CP; Cohn SL J Clin Oncol; 2005 Sep; 23(27):6459-65. PubMed ID: 16116153 [TBL] [Abstract][Full Text] [Related]
20. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]